Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 10, Goldman Sachs resumed coverage of the stock with a ‘Buy’ rating and a $19 ...

Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients ...

Candidates like entrepreneur Vivek Ramaswamy, Sen.Bernie Moreno and Vice President JD Vance are forging a new political path ...

Mary Phillips, the veteran makeup artist and social media maven, will introduce M.Ph, a range of makeup products across ...

A National Science Foundation artificial intelligence institute based at The University of Texas at Austin will receive continued funding for research ...

A new study by payroll-services provider ADP found recent college graduates are having more success in second-tier cities ...

These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

What are Ramblings? Ramblings are a collection of short items that have caught our attention for one reason or another.

Apellis Pharmaceuticals won approval from the FDA to expand the use of its drug Empaveli to include treatment for patients ...

The FDA said it was clearing the way for Sarepta Therapeutics to resume shipments of its gene therapy for Duchenne muscular ...